Visine Original Side Effects
Generic Name: tetrahydrozoline ophthalmic
Note: This document contains side effect information about tetrahydrozoline ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Visine Original.
For the Consumer
Applies to tetrahydrozoline ophthalmic: ophthalmic solution
Side effects include:
Ophthalmic: Blurred vision, irritation, mydriasis.
For Healthcare Professionals
Applies to tetrahydrozoline ophthalmic: compounding powder, ophthalmic solution
Other
Systemic side effects are rare because of the minor extent of absorption after topical application.[Ref]
Ocular
Ocular side effects have included blurred vision, irritation, mydriasis, conjunctival hyperemia, and blepharoconjunctivitis. Conjunctival application, especially when high concentrations have been used in the elderly, may liberate pigment granules, presumably from the iris.[Ref]
Nervous system
Nervous system side effects associated with ocular sympathomimetic agents have included headache, tremor, trembling, dizziness, nervousness, and drowsiness.[Ref]
Cardiovascular
Cardiovascular side effects have rarely included palpitations, hypertension, and bradycardia.[Ref]
References
1. "Product Information. Collyrium Fresh (tetrahydrozoline)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
2. Soparkar CN, Wilhelmus KR, Koch DD, Wallace GW, Jones DB "Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants." Arch Ophthalmol 115 (1997): 34-8
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about Visine Original (tetrahydrozoline ophthalmic)
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Support Group
- En Español
- 1 Review
- Drug class: ophthalmic antihistamines and decongestants
Consumer resources
Other brands: Visine Maximum Redness Relief, Altazine, Geneye Extra, Geneyes, ... +4 more